MHC Class-I Loss and Cancer Immune Escape (eBook)

Artikelnummer: 978-3-030-17864-2
Einband: PDF
Verfügbarkeit: Download, sofort verfügbar (Link per E-Mail)
CHF 177.00
decrease increase

 

This book is about the escape strategies used by cancer cells to avoid the immune response of the host. The main characters of this story are the "Antigen Presenting Molecules" and the "T Lymphocytes". The former are known as the Major Histocompatibility Complex (MHC): the H-2 and the HLA molecules. The latter are a subgroup of white cells travelling all over our body which are capable to distinguish between "self and non self".

Readers will know from the inside about the history of the HLA genetic system and will discover how T lymphocytes recognize and destroy cancer cells. One of the key important questions is: Why tumors arise, develop and metastasize? This book tries to answer this question and will explain how cancer cells become invisible to killer T lymphocytes. The loss of the HLA molecules is a major player in this tumor escape mechanism.

Cancer immunotherapy is aimed at stimulating T lymphocytes to destroy tumor cells. However, the clinical response rate is not as high as expected. The molecular mechanisms responsible for MHC/HLA antigen loss play a crucial role in this resistance to immunotherapy. This immune escape mechanism will be discussed in different types of tumors: lung, prostate, bladder and breast?ect. as well as melanoma and lymphoma.

This book will be useful to Oncologists, Pathologists and Immunologist that will enter this fascinating area of research. It will be also interesting for biologist, doctoral students and medical residents interested in "Tumor Immunology".   



 

This book is about the escape strategies used by cancer cells to avoid the immune response of the host. The main characters of this story are the "Antigen Presenting Molecules" and the "T Lymphocytes". The former are known as the Major Histocompatibility Complex (MHC): the H-2 and the HLA molecules. The latter are a subgroup of white cells travelling all over our body which are capable to distinguish between "self and non self".

Readers will know from the inside about the history of the HLA genetic system and will discover how T lymphocytes recognize and destroy cancer cells. One of the key important questions is: Why tumors arise, develop and metastasize? This book tries to answer this question and will explain how cancer cells become invisible to killer T lymphocytes. The loss of the HLA molecules is a major player in this tumor escape mechanism.

Cancer immunotherapy is aimed at stimulating T lymphocytes to destroy tumor cells. However, the clinical response rate is not as high as expected. The molecular mechanisms responsible for MHC/HLA antigen loss play a crucial role in this resistance to immunotherapy. This immune escape mechanism will be discussed in different types of tumors: lung, prostate, bladder and breast?ect. as well as melanoma and lymphoma.

This book will be useful to Oncologists, Pathologists and Immunologist that will enter this fascinating area of research. It will be also interesting for biologist, doctoral students and medical residents interested in "Tumor Immunology".   



Schreiben Sie Ihre eigene Bewertung
  • Nur registrierte Benutzer können Produkte bewerten
*
*
Schlecht
Sehr gut
*
*
*
*
VerlagSpringer Nature Switzerland
EinbandPDF
Erscheinungsjahr2019
Seitenangabe101 S.
AusgabekennzeichenEnglisch
AbbildungenX, 101 p. 41 illus., 38 illus. in color.
Masse7'371 KB
PlattformPDF
ReiheAdvances in Experimental Medicine and Biology; Biomedical and Life Sciences; Biomedical and Life Sciences
AutorGarrido, Federico

Alle Bände der Reihe "Advances in Experimental Medicine and Biology; Biomedical and Life Sciences; Biomedical and Life Sciences (R0)"

Über den Autor Federico Garrido

Dr. Federico Garrido is Professor Emeritus in the Department of Biochemistry, Molecular Biology and Immunology at the University of Granada Medical School. Prof Garrido was born in Granada (Spain) and obtained his MD and PhD degree in 1974 from the University of Granada. He did his postdoctoral fellowship at the laboratory of Prof Hilliard Festenstein at the London Hospital Medical College and at the Deutsches Krebsforschungszentrum in Heidelberg working on the Immunogenetic of the MHC. In 1981 he became Professor and Head of the Department of Immunology at the University Hospital "Virgen de las Nieves" in Granada. He served as an elected president of the Spanish Society of Immunology (1987-1991) and of the European Federation for Immunogenetics (2004-2008). Dr. Garrido dedicated his scientific career to the investigation of the role of the loss of tumour HLA class-I expression in cancer immune escape.

Weitere Titel von Federico Garrido

Produktbewertungen
Nur registrierte Benutzer können Produkte bewerten